biospecimen__admin__batch_number	231.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	6400C350-50B2-490C-898C-BBFB63759EC7
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A3A4-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A3A4-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A3A4-01A
biospecimen__bio__biospecimen_barcode_bottom	0118957349
biospecimen__bio__day_of_creation	30
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	09
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-A3A4.C755324B-9B82-4319-BDD8-EB8A24107AAC.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A22J
biospecimen__bio__plate_row	H
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A3A4
biospecimen__shared__patient_id	A3A4
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A3A4-A42699
clinical__ablation__bcr_ablation_uuid	E888B66F-EC27-412B-8CDF-A97F9598C732
clinical__ablation__days_to_embolization_performed	231
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Other
clinical__ablation__embolization_therapy_drug_name_other	Mitomycin C and cis-platinum
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	chemoembolic agen
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	F845107B-E7B2-4624-AA3A-3DDE7B77E8EB
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.3
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__child_pugh_classification_grade	B
clinical__chol_lihc_shared__creatinine_lower_level	0.4
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.0
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Other
clinical__chol_lihc_shared__hist_hepato_carcinoma_risk	Tobacco use
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12.0
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	11.0
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	37
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A3A4-F42697
clinical__clin_shared__bcr_followup_uuid	0FEE4F43-5013-4734-81A8-7FFA4CBA00A5
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	27
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	1
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	283
clinical__clin_shared__post_op_ablation_embolization_tx	YES
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	1998
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	87
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-DD-A3A4-D42698
clinical__rx__bcr_drug_uuid	6A8F862A-4110-49E6-8866-C53975BFECBF
clinical__rx__days_to_drug_therapy_end	486
clinical__rx__days_to_drug_therapy_start	459
clinical__rx__drug_name	Gemcitabine
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3
clinical__shared_stage__system_version	5th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	314a10a8-bc55-4a3d-b33d-6d24d5c5b1d0
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A3A4-01A-11R-A22J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	7e95cfaf-4ba9-44ea-bafa-d923d065df32
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.79
gdc__analytes__analyte_id	91f14707-6f56-4163-9db4-d05d29fa48b0
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	ab35c9f9-3040-424d-a89f-dff3a1365bc6
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:44:50.676868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	4dee23bb-3958-531e-8e2d-9cbfb9176343
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1961
gdc__demographic__year_of_death	1999
gdc__diagnoses__age_at_diagnosis	13739
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-13739.0
gdc__diagnoses__days_to_death	612.0
gdc__diagnoses__diagnosis_id	cb8c076e-ce34-5eb6-aef5-b419f3b73d98
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	18.196579043139888
gdc__exposures__exposure_id	295e8a6f-0145-5984-8022-aa899fb6ecf2
gdc__exposures__height	189.0
gdc__exposures__weight	65.0
gdc__file_id	452306f7-acd5-45b5-9f81-0c8f8a97a700
gdc__file_name	74a33529-dde1-4aa5-849f-c8011c4bc26b.mirbase21.mirnas.quantification.txt
gdc__file_size	50048
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	0d94fb49ed9e1eed2fa10eb186722199
gdc__portions__is_ffpe	false
gdc__portions__portion_id	c35ac732-5d02-4478-abe9-0440ac6eb658
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	4776
gdc__samples__initial_weight	160.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	C755324B-9B82-4319-BDD8-EB8A24107AAC
gdc__samples__sample_id	8bcc5576-c437-4ea7-a914-d4b465c8d5dd
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	43c0e21d-3b3e-4126-b3df-cc52ef9a1301
gdc__submitter_id	mirna_swap_dr11_335_MirnaExpression8ca16f6a-8e43-4c5d-a7bd-b315f6622dd8_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	2a67254d-799c-5ee3-888b-a94a2d7e25e8
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:41.452+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/314a10a8-bc55-4a3d-b33d-6d24d5c5b1d0-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/314a10a8-bc55-4a3d-b33d-6d24d5c5b1d0-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129419
manually_curated__local_md5	627bb80cec4133f13378b28ea3134cec
manually_curated__opengdc_download_date	2018-10-16T17:12:28.000757+02:00
manually_curated__opengdc_file_md5	82de98c57bc93ec41d8e03782375960a
manually_curated__opengdc_file_size	50047
manually_curated__opengdc_id	314a10a8-bc55-4a3d-b33d-6d24d5c5b1d0-meq
manually_curated__origin_file_size	129419
manually_curated__origin_last_modified_date	Tue Oct 16 17:50:00 CEST 2018
manually_curated__origin_md5	627bb80cec4133f13378b28ea3134cec
manually_curated__tissue_status	tumoral
